Entest Group Inc is a blank check company. The Company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses or entities. The Companyâ€™s current business plan is to seek new business opportunities or to engage in a business combination with an unidentified company. The Company has no operations and has not generated revenues.

Employees

Sector

Investment Holding Companies

More about the company

Market Cap	541K 466K 429K 403K 757K 51.14M 765K 5.07M 1.98M 25.04M 2.03M 1.99M 86.78M	P/E Ratio 2018	-0.92x	P/E Ratio 2019	12.6x
Enterprise Value	562K 484K 446K 419K 786K 53.14M 795K 5.27M 2.05M 26.02M 2.11M 2.06M 90.19M	EV / Sales 2018	-	EV / Sales 2019	-
Free-Float	98.54%	Yield 2018 *	-	Yield 2019	-

20-01-21	Entest Group, Inc. Reports Earnings Results for the First Quarter Ended November 30, 2019	CI
19-12-20	Entest Group, Inc. Reports Earnings Results for the Full Year Ended August 31, 2019	CI
19-07-15	Entest Group, Inc. Reports Earnings Results for the Third Quarter Ended May 31, 2019	CI
19-01-22	Entest Group, Inc. Reports Earnings Results for the First Quarter Ended November 30, 2018	CI
18-12-03	Entest Group, Inc. Announces Management Changes	CI
18-11-26	Peiwen Yu completed the acquisition of 48.3% stake in Entest Group, Inc. from Regen BioPharma, Inc., Bostonia Partners, Inc, Dunhill Ross Partners, Inc., Bio-Technology Partners Business Trust, David Koos and Sherman Family Trust.	CI
18-11-19	Peiwen Yu entered into an agreement to acquire 48.3% stake in Entest Group, Inc. from Regen BioPharma, Inc., Bostonia Partners, Inc, Dunhill Ross Partners, Inc., Bio-Technology Partners Business Trust, David Koos and Sherman Family Trust for $0.33 million.	CI
18-02-14	ENTB will Change its Name to ETNI	CI
15-11-26	Entest Group, Inc. Auditor Raises 'Going Concern' Doubt	CI
15-08-21	Entest Biomedical, Inc. will Change its Ticker to ENTB from ENTB.D	CI
15-07-27	Entest Biomedical, Inc. will Change its Ticker to ENTBD from ENTB	CI
14-07-16	Christine Ichim Joins Entest BioMedical Inc. as Director of Research	CI
13-03-06	Entest Biomedical Mulls Acquisitions	CI

20-01-21	ENTEST : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	AQ
20-01-07	ENTEST GROUP, INC. : Changes in Registrant's Certifying Accountant (form 8-K)	AQ
19-12-20	ENTEST : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	AQ
18-05-10	Entest Group, Inc. : Declares Property Dividend of 3,000,000 Common Shares of Zander Therapeutics Inc.	PR
17-09-13	Entest Biomedical : Zander Therapeutics, Inc. Announces Appointment of Dr. Robin Beat Gasser to Scientific Advisory Board	PR

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ENTEST GROUP, INC.	-2.86%	-.--%	-	-	9.83K
FACTORIAL ENERGY INC.	-7.01%	+12.68%	-	-	1.66B
EINRIDE AB	+0.49%	0.00%	-	-	1.42B
AIR GLOBAL PLC	+1.88%	+3.69%	-	-	1.28B
PRIME BEING CORP.	-35.29%	-35.29%	+44.74%	+391.07%	797M
CENTIEL AG	+1.57%	+60.08%	+413.19%	-61.10%	788M
DRUGS MADE IN AMERICA ACQUISITION II CORP.	+0.05%	0.00%	-	-	642M
BAIN CAPITAL GSS INVESTMENT CORP.	0.00%	-0.29%	-	-	596M
CANTOR EQUITY PARTNERS IV, INC.	+0.10%	+0.58%	-	-	590M
Average	-4.26%	+6.77%	+228.96%	+164.99%	972.4M
Weighted average by Cap.	-4.16%	+5.41%	+227.94%	+166.25%

	2018	2019
Net sales	-	-
Net income	-1.48M -1.27M -1.17M -1.1M -2.07M -140M -2.09M -13.85M -5.4M -68.41M -5.54M -5.43M -237M	192K 165K 152K 143K 268K 18.12M 271K 1.8M 700K 8.87M 719K 704K 30.75M
Net Debt	19.4K 16.72K 15.4K 14.45K 27.14K 1.83M 27.43K 182K 70.87K 898K 72.81K 71.26K 3.11M	21.2K 18.27K 16.82K 15.79K 29.65K 2M 29.97K 199K 77.44K 981K 79.55K 77.86K 3.4M

Entest Group, Inc. Stock Other OTC

Stocks

ETNI

US29383T3005

Investment Holding Companies

Valuation: Entest Group, Inc.

Latest news : Entest Group, Inc.

Press Releases: Entest Group, Inc.

Quotes and Performance

Managers and Directors: Entest Group, Inc.

Shell Companies

Financials

Company Profile